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Summary 
Class II major histocompatibility complex encoded proteins (MHC class II or Ia molecules) are 
principal plasma membrane proteins involved in activation of both B and T cells during antigen- 
driven immune responses. Recent data indicate that class II molecules are more than simply 
recognition elements that provide a ligand for the T  cell antigen receptor. Changes in B cell 
physiology that follow class II binding are now recognized as being required not only for the 
induction of T  cell activation, but also for B cell activation and proliferation. It is interesting 
to note that class II molecules appear to transduce signals via two distinct mechanisms depending 
upon the differentiative state of the B cell on which they are expressed. While one of these pathways, 
involving  cAMP  generation  and  protein  kinase  C  localization  in  the  cytoskeletal/nuclear 
compartment, is seen in resting B cells, the second is seen in primed B cells and involves tyrosine 
kinase  activation,  inositol  lipid  hydrolysis,  and  Ca  2+  mobilization.  Use  of this  pathway is 
correlated with ability of class II to transduce signals  leading to B cell proliferation. To begin 
to address the molecular basis of this unique, activation-dependent, differential coupling of class 
II to signaling pathways, we conducted mutational analysis of class II structural requirements 
for signal transduction.  Here we report that  the cytoplasmic (Cy) domains of I-A  k class  II 
molecules are not required for either receptor-mediated activation of  protein tyrosine phosphorylation 
or Ca  2+  mobilization. This is in contrast to the requirement of the Cy domain of beta chain 
of class II for the alternate signaling pathway and efficient antigen presentation to autoreactive 
T cell lines. Disparate distribution of functional motifs within the MHC class II molecules may 
reflect use of distinct receptor associated effector molecules to sustain different modes of signal 
transduction in various class II-expressing cells. 
T 
he evolution and maintenance of the polymorphisms of 
MHC class II molecules for the singular role of binding 
peptide antigen for presentation to T  cells may have been 
complemented by the  strict  conservation  of amino  acids 
(monomorphisms) in the transmembrane (TM)  and cyto- 
plasmic (Cy) domains in order to maintain the ability to ex- 
ercise multiple signaling functions. With respect to signaling 
via class II molecules (1), it is appreciated that the amino acids 
of the TM and Cy domains are as critical to function of the 
class II molecule as are the amino acids that comprise its pep- 
tide binding site. The six COOH-terminal amino acids of 
the a  chain are implicated in controlling the translational 
diffusion (2) of class II molecules while the Cy domain of 
both a  and/3 determine its efficiency  in antigen presentation 
(3-5, and Wade, W.F., personal observation). The basis of 
the later effect is not known, but it is thought to reflect a 
necessity that the molecule transmit a transmembrane signal 
for effective antigen presentation or that interaction of these 
molecules with other components at the plasma membrane 
is needed for the correct, optimal orientation of the class II 
molecule for T  cell recognition (6-8). While the 18-amino 
acid beta chain Cy domain of class II has been found to con- 
trol the translocation of  protein kinase C to the cytoskeletal/nu- 
clear compartment after class II receptor engagement, it has 
also been implicated in contributing to antigen presentation 
efficiency, especially presentation to autoreactive T  cells (3, 
4,  9,  10). Recently studies of several groups have revealed 
that MHC class II molecules alternately use an additional 
signaling mechanism involving rapid activation of a protein 
tyrosine kinase, Ca  2+ mobilization, and hydrolysis of phos- 
phatidylinositol 4,5-bisphosphate (PdtlnsP2) yielding diacyl- 
glycerol  (DAG),  and  inositol  1,4,5-trisphosphate  (InsP3) 
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in calls that have been activated by antigen surrogate anti-Ig 
antibodies, IL-4 receptor ligation (11, 14), or CD40 ligand 
stimulation (Andr6,  P.,  and J. C.  Cambier, manuscript in 
preparation). The use by the same receptor of alternate sig- 
naling pathways depending upon the differentiative context 
is novel in biology, and of likely importance in the immune 
response. This prompted us to undertake structure/function 
analysis of the Cy domains of  chss II to determine if the amino 
acids that control previously defined function overlap with 
the amino acids that control the ability of the receptor to 
mediate and activate tyrosine phosphoryhtion Ca  2§  mobili- 
zation. 
Materiah and Methods 
Pre~ration of Transfictants.  K46J,  an bA  d positive B cell lym- 
phoma was maintained in IMDM medium supplemented  with 5% 
FCS, 100 U/ml penicillin, 100/~g/ml streptomycin, 1 mM sodium 
pyruvate, 2 mM glutamine, and 5  x  10-s M 2-ME. Transfection 
was  accomplished via  electroporation  with  an  electroporator 
(GIBCO BRL, Gaithersburg,  MD) using previously  described  con- 
structs (10) (Table 1). Briefly, 5  x  106 cells were pulsed in the 
presence of 20/~g each of linearized genomic DNA for the A~ and 
A~ chains, as well as 5/~g of pSV2-neo. The settings for the pulse 
were 50/~F, low impedence,  and 300 V. After electroporation, cells 
were cultured (10'-10S/ml) in 24-well plates for 16 h before the 
addition of G418 to a final concentration of 1 mg/ml. Resistant 
cells from wells exhibiting clonal growth were subcloned and ana- 
lyzed for surface expression levels of I-A  k by exposing cells to bi- 
otinylated anti-I-A  k (mAb) 39J (20/~g/ml per 107 cells), and then 
to fluoresceinated  avidin (1/100; Tago, Inc., Burlingame, CA) be- 
fore analysis  by flow cytometry (10). Cells that were used in these 
studies expressed  various  phenotypes of MHC class II that had been 
mutated by the addition of premature stop codons (10): K46J 17.4 
(wt/wt, wild type c~ and fl chains). The c~ chain phenotype is always 
listed first. K46J 73.35 (otCT12//3CT12, CT refers to a COOH- 
terminal truncation and the number indicates how many amino 
_~__'ds are missiag  from the COOH terminus)  K46J  25.1 (<xCI~/wt), 
K46J 1.6.24 (wt//$CT12), K46J 7.1 (otCT12//$CT18), and K46J 
7.5 (<~CT12//3CT18). As predicted by studies of Germain et al. 
(15), immunochemical analysis  of these cells revealed no evidence 
of mixed molecule I-Ak/I-M formation (data not shown). 
Analysis of lntracellular Free Calcium [Ca2+]i.  [Ca2+li analysis 
was performed as described  previously  (11). K46J were loaded with 
Indo-1 AM (Molecular Probes Inc., Eugene, OK) coated with bi- 
otinylated  antibodies including  anti-I-A  a,b  (20  /~g  D3.137/107 
cells/ml), anti-I-A  k (20/zg 39J/107 cells/nil), anti-H-2K  a (25/~g 
34.5.8s/107 cells/ml), or anti-B220 (12/~g R.A3.3A1/107 cells/ml), 
and washed and resuspended at 106 cdls/ml. [CaZ+]i levels were 
analyzed  by flow cytometry before  and after stimulation with avidin 
(10 #g/m1; Sigma Chemical Co., St. Louis, MO).  D3.137 mAb 
was a gift from Dr. Sue Tonkonogy, North Carolina State Univer- 
sity School  of  Veterinary  Medicine  (Raleigh, NC). Other antibodies 
were obtained from the American Type Culture Collection (Rock- 
ville, MD). Analyses  were conducted  using a flow cytometer (model 
50H; Ortho Diagnostic Systems, Westwood, MA) with an ap- 
pended data acquisition system and MTIME software (both from 
Phoenix Flow Systems, San Diego, CA). 
Anal}sis of Induction of Protein Tyrosine Phosphorylation.  B lym- 
phoma cells were washed twice and resuspended in IMDM at 107 
cells/ml. Saturating concentrations of biotinyhted anti-I-A  i (20/~g 
39J/ml) were added and cells were incubated for 15 rain at room 
temperature. Unbound antibody was removed  by washing one time 
before cells were resuspended at 5  x  106 cells/50/~1 per sample. 
Primary antibodies were cross-linked by addition of 4/~g avidin/ 
sample. After incubation for varied time periods at 37~  reactions 
were terminated by addition of an equal volume of 2 x  ice-cold 
Table  1.  Primary Amino Acid Sequence of the Connecting Peptide, Transmembrane, and Cytoplasmic Domains of I-A ~ 





















The primary amino acid code for the truncation phenotypes of I-Ak that were expressed in K46J, a B cell lymphoma. The transmembrane (TM) 
sequence is underlined; the cytoplasmic  (Cy) domain amino acids are to the right of the underlined sequences and the connecting  peptide (CP) is 
to the left. CT and then a number indicates a COOH-terminal truncation of the indicated  number of amino acids. The generation of the mutant 
I-AL-encoding  genomic  clones has been described elsewhere (6). Genomic  constructs for the various combinations  of the o< and/~  chins, along  with 
the construct  pSV2-neo were transfected  into K46J ceils. G418-resistant  clones  were isolated and screened secondarily  by immunofluorescence  staining 
with FITC-anti-I-A  k antibodies. 
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date, 10 mM sodium pyrophosphate,  10 mM Tris-HC1 (pH 7.3), 
1 mM phenylmethylsulfonyl fluoride, 0.4 mM EDTA, 10 mM so- 
dium fluoride, 2 #g/ml aprotinin, 2 #g/ml lenpeptin, and o~-l-anti- 
trypsin (2 #g/ml). After lysis at 4~  nuclei were pelleted and post- 
nuclear supernatants were boiled in SDS sample buffer, subjected 
to SDS-PAGE on a 8% gel, and transferred onto Immobilon (Mil- 
lipore Corp., Bedford, MA). Membranes were blocked overnight 
at 4~  with 5% bovine albumin (Cohn crystallized; ICN Biomed- 
icals, Costa Mesa, CA) in 10 mM Tris (pH 8) and 150 mM NaC1 
(Tris buffered saline [TBS]), and then probed with an anti-phospho- 
tyrosine antibody (Ab-2; Oncogene Science Inc., Manhasset, NY) 
for 2 h at room temperature. After washing, the immunoblots were 
incubated with a rabbit anti-mouse IgG1 antibody (Zymed Labs., 
In~, S. San Francisco, CA) for 1 h at room temperature, then washed 
before exposure to azSI protein  A for 1 h at room temperature, 
washed again,  and then  subjected to autoradiography. 
Results 
The analysis  of MHC class II structural requirements for 
Ca  2+ mobilization after class II ligation was made possible 
by the discovery (see Fig.  2) that  in the B cell lymphoma 
K46J,  cross-linking  of endogenous  MHC  class  II  (I-A  d) 
molecules triggers the Ca  2  + mobilization pathway seen both 
in human and mouse peripheral B cells (11, 12, 13). We there- 
fore constructed transfectants of K46J that express previously 
described mutant  I-A  k molecules (10) with various combi- 
nations  of truncated cr or/3 chains,  or both.  The mutants 
are defined in Table 1. These transfectants were selected with 
1 mg/ml G418, cloned by limiting-cell dilution and analyzed 
for surface expression levels of I-A  ~, Fig.  1.  It can be seen 
that  the  relative expression  of mutant  I-A  ~ on individual 
transfectants is within a twofold of range of wild type and 
there is considerable overlap in expression between the trans- 
fectant 17.4 (wt/wt) with that of the most extreme trunca- 
tion phenotype clone, 7.5, which lacked the COOH-terminal 
cytoplasmic 12 amino acids of the cr chain and 18 amino acids 
of/3 chain  (c~CT12//3CT18).  No staining  of K46J parents 
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Figure  1.  Analysis for surface expression levels of I-A  k in transfected 
K46J B lymphoma. Cells were exposed to biotinylated anti-I-A  k (mAb) 
and then to fluoresceinated avidin before analysis  of flow cytometry. Shown 
are the immunofluorescence histograms of K46J parent cells (control),  K46J 
17.4 (wt/wt) (5), K46J 73.35 (olCT12/flCT12) (6). K46J 25.1 (c~CT12/wt) 
(1), K46J 1.6-24 (wt/13C~2) (4), K46J 7.1 (~xCT12/~CT18) 0), and K46J 
7.s (~CTUI~CT18) (2). 
crossreactive antigens.  All K46J transfectants expressed en- 
dogenous FAd at the same level when analyzed by the mAb 
D3.137 (data not shown).  The I-A  a and I-A  k expressed by 
transfectants  were insensitive  to PLC digestion indicating that 
none  of the  transfected  gene  products  was  expressed  in 
phosphatidylinositol-glycan linked form (data not shown). 
The K46J transfectants  were tested for their ability to mobi- 
lize Ca  2+ through either the endogenous wild type I-A  d or 
the transfected genes' product,  I-A  k.  It can be seen in Fig. 
2  that  three  transfectants  17.4  (wt/wt),  73.35  (c~CT12/ 
/3CT12),  and 7.1 (c~CT12//3CT18)  undergo Ca  2+ mobiliza- 
tion  response  after cross-linking  of I-A  k by the  anti-I-A k 
mAb 39J  (IgG2a  anti-oL chain).  These responses appeared 
equivalent to that mediated through their endogenous I-A  a. 
Similar  responses were made by transfectants  that  express 
I-A  k with truncation phenotypes otCT12/wt or wt//3CT12 
(data not shown). Equivalent responses were seen when the 
anti-I-A k antibody 10.2.16  (IgG2b anti-/3 chain) was used as 
stimulus but cells  did not respond  to the anti-H2K a anti- 
body (34.5.8s,  IgG2a) or to anti-B220 (RA3-3A1) demon- 
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Figure 2.  Cross-linking of wild type or truncated I-A  k molecules in- 
duce Ca  2+ mobilization in K46J. K46J (wt/wt) (.4 and B), K46J 73.35 
(otCTI2/flC-'TI2) (C and D) and K46J 7.1 (otC-T12/BCTI8) (E and F) were 
loaded with Indo-1 as described (11), coated with biotinylated anti-I-Aa,  b 
(20 #g D3.137/107 cells/ml) (.4, C, and E) or biotinylated anti-I-Ak (20 
#g  39J/107 cells/ml)  (B,  D,  and F),  washed  and resuspended at  106 
cells/m1. [Ca2+]i levels were analyzed by flow cytometry before and after 
stimulation with avidin (10/zg/ml, Sigma Chemical Co.) added at arrow. 
Data shown in this and subsequent figures are representative of more than 
three replicate experiments. 
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could mediate a Ca  2+ mobilization after their ligation,  the 
isometric analysis of the data indicated  that maximal responses 
and response kinetics differed somewhat among subdones. 
Therefore we conducted a more quantitative analysis of class 
II-mediated  Ca  2+  fluxes in the subclones. 
Quantitative comparison of the ability of mutant receptors 
expressed by subclones of K46 to transduce signals leading 
to Ca  2  + mobilization required that we correct for (a) poten- 
tial variations in intrinsic ability of individual subclones to 
signal through  Ia and (b) clonal differences in I-A  k expres- 
sion that  might  limit  signal transduction.  We normalized 
for the intrinsic ability of dories to signal through Ia based 
on relative responses to cross-linking  of their  endogenous 
I-A  a (Table  2).  The maximum  mean  intracellular  flee cal- 
cium concentration  (m[Ca2+]i)  seen  in  response  to cross- 
linking  of the  endogenous  I-A  a was determined  for each 
subclone. We then established the proportionality between 
this  response  and  that  of the  K46J17.4  subdone  expres- 
sing wild-type I-A k, e.g., (m[Ca2+]i  of anti-I-Aa-stimulated 
K46J7.1)/(m[Ca2+]i  of anti-I-Ad-stimulated  K46J17,4)  = 
230/340  =  0.68.  Using this factor we normalized  the in- 
trinsic responsiveness of each subclone to K46J17.4. To then 
normalize the I-A  k responses of each subclone, e.g., K46JT.1, 
to  that  of the  wild-type  I-A  k  subclone  (K46J17.4),  we 
divided the normalization  factor for each subclone, in this 
case, 0.68, into the particular subclone's m[Ca2+]i  response 
to anti-I-AL  This corrected value is referred to as normal- 
ized m[Ca2+]i (see Table 2). It should be noted that expres- 
sion of I-A  d was essentially identical in all clones and the 
m[Ca2+]i  response of clones to  anti-LA d did not  vary by 
more than  20%, 
To accommodate potential effects of differential I-A  k ex- 
pression on the responses observed, we first established the 
relationship  between  the  relative  number  wild-type  I-A  k 
molecules ligated and the magnitude of the subsequent Ca  2  + 
response.  Saturating  and  subsaturating  doses  of anti-I-A k 
mAb (39J) were used to define this relationship in K46J 17.4 
(wt/wt). Indo-l-loaded ceils were exposed to varied concen- 
trations  of biotinylated anti-I-A ~..  Cells were then washed 
and samples were divided and subjected to analysis of [Ca  2  +  ]i 
before and after cross-linking of biotinylated anti-I-A k with 
excess avidin.  Alternatively,  relative I-A  k molecules ligated 
on cells were quantitated by exposure of the paralld samples 
to fluoresceinated  avidin, followed by analysis ofimmunofluo- 
rescence by flow cytometry. As shown in Fig. 3, ligation of 
as few as 20% of wild-type I-A  k molecules on K46J17.4 cells 
led to a detectable [Ca2+]i response.  The magnitude of the 
response was directly correlated with levds of receptor liga- 
tion when 20--60%  of I-A  k were ligated.  Above this level 
of receptor ligation  the response was maximal. 
Based on this relationship, it was possible to predict what 
response should result from ligation of any number of nor- 
mally functional  I-A  k molecules  on clones that  expressed 
mutant I-A  k. For each mutant done we simply plotted the 
normalized m[Ca2+]i  seen after I-A  k stimulation against  I-A  k 
bound using saturated staining of K46J17.4 (wt/wt) I-A  k as 
100%  (as  above).  Mutants  whose response equaled  those 
predicted  for  wild-type  I-A  t  were  considered  not  to  be 
defective. As can be seen in Fig. 3, normalized  [Ca  2§ ]i re- 
sponses of mutant  I-Ak-bearing cells were similar in mag- 
nitude to those of wild-type I-AL-bearing cells under con- 
ditions of comparable I-A  ~ ligation.  Thus the Cy domains 
of class II molecules are not required for receptor mediation 
of Ca  2  + mobilization  after class  II ligation. 
The earliest detectable event in Ia-mediated signaling in 
normal routine B cells and K46 cells is inductive protein tyro- 
sine phosphorylation  (13).  Further,  previous  studies  have 
demonstrated that the Ia-mediated [Ca  2+ ]i responses are de- 
pendent on protein tyrosine kinase activity indicating  that 
these events are causally related (11). To determine whether 
mutant I-A  k molecules are normal in terms of their ability 
to activate protein tyrosine phosphorylation, we stimulated 
K46J17.4  (wt/wt)  and  K46J7.1  (o~CT12/t~CT8)  with  bi- 
otinylated  anti-I-A k antibody  and  avidin  for  varied  time 
periods and analyzed changes in whole cell tyrosine phos- 
Table  2.  Normalization  of Anti-I-A ~ Responses for the Clone's Intrinsic Ability  to Mobilize  Calcium After 1-,4 Cross-linking 
(subclone m[Ca~§  to anti-I-Ad)/  Normalized  I-A  k 
Subclone  m[Ca2+]i*  to anti-I-A d  (K46J17.4 m[Ca2+]i to anti-LA d)  m[Ca2+]i  to anti-I-A k  response* 
Relative  I-A  k 
expression 
(percent  17.4) 
nM  nM  nM 
7.1  230  0.68  160  235  43 
7.5  230  0.68  135  198.5  31.5 
73.35  270  0.79  255  323  96 
25.1  280  0.82  130  158.5  31 
1.6-24  270  0.79  235  297  91 
17.4  340  1  320  320  100 
* Maximum mean intracellular free Ca  2+ concentration, resting [Ca2+]i was 70 nM. 
* (Subclone X m[Ca2+]i to anti-I-Ak)/[(subclone X m[Ca2§  to anti-I-Aa)/(K46J17.4 m[Ca2+]i to anti-I-Ad)] =  normalized I-A  k response. 
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Figure 3.  Tailless  I-A molecules are competent "Ca  2+'' signal t~ns- 
ducers. The anti-I-A  k mAb, 39J, was titrated with K46J 17.4 (wt/wt). 
Some cells were loaded with Indo-1 before exposure to decreasing concen- 
trations of biotinylated anti-I-A  k, washed, and then subjected to analysis 
of [Ca2+]i before and after cross-linking  of biotinylated  anti-I-A  k with 
excess avidin, otCT12/BCT18  (7.1) and otCT12/~CT18  (7.5) designate 
two distinct clones, 2 and 3, respectively, in Pig. 1. The maximum mean 
change in [Ca2+]i  was determined as described (11). 
phoproteins patterns by anti-phosphotyrosine immunoblot- 
ting of clectrophoretic transfers  of SDS-PAGE fractionated 
whole call lysates. As shown in Fig.  4,  the wild-type and 
c~CT12//3CT18 I-A  k molecules transduced signal leading to 
apparently equivalent protein tyrosine phosphorylation. The 
same tyrosine phosphoprotein  patterns were found by cross- 
linking LA  d on K46J (data not shown). Notable is induc- 
ible phosphorylation of three dominant substrates Mr ",,93k, 
64k, and 60k (see arrows) through both wt/wt and tailless 
oeCT12/13CT18 I-A  k molecules. Surprisingly, in the experi- 
ment shown, stimulation lead to an apparent reduction in 
phosphorylation of proteins of ",,106 and 75 k. This effect 
was not seen reproducibly. Thus deletion of the entire cyto- 
plasmic tails of cx and/3 does not affect the coupling of I-A 
to protein tyrosine kinase activation. 
Discussion 
Data presented demonstrate that the cytoplasmic tails of 
I-A~  and  I-At~ chains  are  not  required  for  MHC  class 
II-mediated transmembrane signal transduction leading to 
protein tyrosine phosphorylation and calcium mobilization. 
Other receptor systems including  mIg, CD2, TCR-~', PDGF, 
EGF, and CD3 differ from class II in that sequences respon- 
sible  for  receptor-mediated Ca  2+  mobilization  are  found 
within Cy domains (16-20).  It should be noted that the Cy 
domains of these molecules are appreciably larger than those 
of either the tx or/3 chain of class II. Class II is similar to 
Figure 4.  Kinetics of I-A  t cross-linking-triggered induction  of protein 
tyrosine  phosphorylation  in  K46J  17.4  (wt/wt)  and  K46J  7.1 
(otCTI2/3C'I'I8).  The cells were coated with biotinylated 39J and then 
stimulated with avidin for 0-8 min as indicated. Reactions were stopped 
with ice cold lysis buffer and total cell lysate proteins were resolved by 
SDS-PAGE dectrophoresis, tnmferred to immobilon,  and immunoblotted 
with antiphosphotyrosine, followed by a2SI-protein  A and autoradiography, 
as described in Materials and Methods. The tool wt markers are as indi- 
cated. (Arrows) Position of pp93, pp64, pp60.  (Lane - -) Uncoated cells. 
the class I MHC molecule in not requiring a Cy domain in 
order tO signal Ca  2  + mobilization (21). A conceptual under- 
priming of the fact that MHC class II and class I molecules 
can mediate Ca  2+ fluxes without Cy domain amino acids is 
provided by the recent observation that glycophosphoinositol- 
linked plasma membrane proteins such as CD55 and CD58, 
Ly6, and Thy 1 mediate tyrosine kinase activation and in some 
cases Ca  z+ mobilization in the absence of cytoplasmic struc- 
ture (22, 23). Thus there is no a priori requirement that tyro- 
sine kinase coupled receptors such as I-A possess cytoplasmic 
domains. Presumably these molecules activate  cytoplasmic 
effector pathways by virtue of interaction with other cell s~ 
molecules which in turn transduce protein tyrosine kinase- 
activating signals. 
Perhaps most importantly, the findings reported here in- 
dicate that distinct sequence motifs confer distinct functional 
potential upon MHC class II molecules. Both ce and 13 chains 
contain sequences that are required for dfident antigen pre- 
sentation (3, 4). The individual chains also have unique func- 
tions: the COOH-terminal 6 Cy domain amino acids of c~ 
chains appear to interact with cytoskcletal dements that de- 
termine the rate of  translation di~sion ofdass II in the plasma 
membrane (2), while the sequence that mediates protein ki- 
nase C cytoskcletal/nuclear interaction is localized in a very 
basic six-amino acid motif adjacent to the plasma membrane 
in the beta chain Cy domain (5, 10). In view of the fact that 
these multiple functions are encoded in rclatively  short Cy 
domains, 12 and 18 amino acids for the oe and/3 chains, respec- 
tively, it is perhaps not surprising that the amino acid se- 
quences that mediate protein tyrosine kinase activation and 
Ca  z+ mobilization response are in either the TM or ecto do- 
mains of the c* and/or/3 chains. 
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